Skip to content

Sanofi, U.S. Military to Work on Zika Vaccine Development

Bloomberg reports that “Sanofi will partner with the U.S Walter Reed Army Institute of Research to develop a Zika vaccine candidate using an inactivated version of the virus.”  

“Walter Reed, a military biomedical research institute within the Department of Defense, will transfer its purified inactivated virus vaccine technology to Sanofi’s vaccines division. The Paris-based drugmaker will be responsible for handling human trials, improving production yields, and creating a clinical and regulatory strategy, according to a statement Wednesday.”  

“Sanofi is the only major pharmaceutical company that has been actively pushing to develop a vaccine for Zika, a mosquito-borne virus that has been spreading across the Americas and is a major threat mainly to pregnant women, as it can trigger severe birth defects. The partnership will open the door for a broader collaboration with the U.S. government, Sanofi said.”

Recent Stories

DHS tightens protocol for lawmaker visits to immigration facilities

Senate Republicans echo Trump allegations on Biden autopen use

At the Races: The politics of war

On Iran strikes messaging, Trump aides opt to run it up the flagpole

Anthony D’Esposito looks to go from cop to congressman to inspector general

Outlook darkens for Social Security, Medicare solvency